TABLE 3.

Clinical outcomes compared between fluoroquinolone and beta-lactam oral step-down therapies (n = 220)

Characteristica	No. (%) of patients		P value
	FQ group (n = 87)	BL group (n = 133)
Clinical success	80 (92.0)	124 (93.2)	0.7209
Reason for clinical failure
90-day all-cause mortality	2 (2.3)	0 (0)	0.1553
90-day infection-related readmission	6 (6.9)	9 (6.8)	0.9702
90-day recurrent BSI with the same organism	1 (1.2)	2 (1.5)	1
C. difficile-associated diarrhea	3 (3.5)	4 (3.0)	1
Antibiotic-associated adverse events
Diarrhea	3 (3.4)	5 (3.8)
Rash	2 (2.3)	3 (2.3)
QT interval prolongation	1 (1.1)	0 (0)
Nausea/vomiting	1 (1.1)	0 (0)

^aBSI, bloodstream infection.